REGEN BIOPHARMA, INC. Net Change in Cash
REGEN BIOPHARMA, INC. (RGBP) reported Net Change in Cash of -$69.32 thousand for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2026-08-17
- REGEN BIOPHARMA, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2025-12-31 was -$64.98K.
- REGEN BIOPHARMA, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-12-31 was -$581.00, a 116.79% decline year-over-year.
- REGEN BIOPHARMA, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-12-31 was $3.46K.
- REGEN BIOPHARMA, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2025 was $68.84K.
- REGEN BIOPHARMA, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was -$120.32K, a 272.30% decline from fiscal 2023.
- REGEN BIOPHARMA, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was $69.83K.
- REGEN BIOPHARMA, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$675.96K, a 192.96% decline from fiscal 2021.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$69.32K 10-Q · filed 2026-08-17 | |||||
| 2026-03-31 | -$69.28K 10-Q · filed 2026-05-14 | |||||
| 2025-12-31 | -$64.98K 10-Q · filed 2026-02-13 | |||||
| 2025-09-30 | $68.84K 10-K · filed 2025-12-30 | |||||
| 2025-06-30 | $1.04K 10-Q · filed 2026-08-17 | |||||
| 2025-03-31 | $1.05K 10-Q · filed 2026-05-14 | $1.04K 10-Q · filed 2025-05-28 | ||||
| 2024-12-31 | -$581.00 10-Q · filed 2026-02-13 | |||||
| 2024-09-30 | -$120.32K 10-K · filed 2025-12-30 | -$120.32K 8-K · filed 2024-11-29 | ||||
| 2024-06-30 | -$59.19K 10-Q · filed 2025-08-11 | |||||
| 2024-03-31 | -$42.92K 10-Q · filed 2025-05-28 | |||||
| 2023-12-31 | $3.46K 10-Q · filed 2025-05-16 | |||||
| 2023-09-30 | $69.83K 10-K · filed 2025-05-13 | |||||
| 2022-09-30 | -$675.96K 10-K · filed 2022-11-15 | |||||
| 2021-09-30 | $727.16K 10-K · filed 2022-11-15 |